These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia]. Cui YJ; Jiang Q; Liu JQ; Li B; Xu ZF; Qin TJ; Zhang Y; Cai WY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):28-32. PubMed ID: 28219221 [No Abstract] [Full Text] [Related]
8. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229 [TBL] [Abstract][Full Text] [Related]
9. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia. Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813 [TBL] [Abstract][Full Text] [Related]
10. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review. Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671 [TBL] [Abstract][Full Text] [Related]
11. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications. Mitsumori T; Komatsu N; Kirito K Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968 [TBL] [Abstract][Full Text] [Related]
15. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies. Kim SY; Song IC; Kim J; Kwon GC Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470 [TBL] [Abstract][Full Text] [Related]
16. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management. Szuber N; Orazi A; Tefferi A Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693 [TBL] [Abstract][Full Text] [Related]
17. Genetic Response of Chronic Neutrophilic Leukemia With CSF3R T618I, SETBP1, and ASXL1 Mutations After Decitabine Therapy. Cao S; Tao Q; Wang J; Zhang Q; Dong Y Am J Ther; 2024 Sep-Oct 01; 31(5):e550-e552. PubMed ID: 39292831 [No Abstract] [Full Text] [Related]
18. Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review. Gao JP; Zhai LJ; Gao XH; Min FL J Clin Lab Anal; 2022 Apr; 36(4):e24287. PubMed ID: 35170077 [TBL] [Abstract][Full Text] [Related]
19. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms. Carratt SA; Kong GL; Curtiss BM; Schonrock Z; Maloney L; Maniaci BN; Blaylock HZ; Baris A; Druker BJ; Braun TP; Maxson JE Blood; 2022 Aug; 140(6):644-658. PubMed ID: 35482940 [TBL] [Abstract][Full Text] [Related]
20. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form. Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]